$10 million funding for phenomics research
The Australian Government has announced a $10 million investment in the Translational Phenomics Initiative to help advance critical understanding of disease mechanisms and validate approaches to new therapies.
The Translational Phenomics Initiative, hosted at the Australian National University (ANU), uses discoveries made from genome sequencing to drive development of new disease models, novel diagnostics and better treatment for patients with chronic illnesses.
The investment will significantly progress the translation of the massive amount of existing genomic data and support the broad application of precision and personalised medicine, said ANU Deputy Vice-Chancellor (Research and Innovation) Professor Keith Nugent.
“Currently, we only know the significance of a tiny fraction of the human genome, and we know even less about how the genome connects to disease,” said Prof Nugent.
“Phenomics relates our genome to the development of potential therapies and so is central to the emerging area of precision medicine.
“The Australian Government’s investment in this critical work will go a long way to improving the lives of the millions of people who suffer from chronic and debilitating illnesses,” he said.
The federal government funding injection complements investments from the ACT Government to support clinical research. ANU has invested more than $10 million to support research projects in precision medicine across the university.
Exclusive colostrum intake may reduce risk of food allergies
Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
Low-dose drug prevents diabetes progression in young people
A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...
